Eaton Vance Management Pacira Bio Sciences, Inc. Transaction History

Eaton Vance Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $64,412 - $82,073	-1,073 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $27,342 - $35,459	570 Added 113.32%	1,073 $0
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $14,370 - $16,121	-263 Reduced 34.33%	503 $0
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $22,961 - $27,156	388 Added 102.65%	766 $47,000
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $22,419 - $29,793	378 New	378 $26,000
Q2 2018 Aug 10, 2018	SELL	$27.5 - $39.8 $3.73 Million - $5.4 Million	-135,553 Closed	0 $0
Q1 2018 May 07, 2018	SELL	$29.98 - $46.35 $2.09 Million - $3.23 Million	-69,583 Reduced 33.92%	135,553 $4.22 Million
Q3 2017 Nov 13, 2017	BUY	$35.7 - $39.5 $7.32 Million - $8.1 Million	205,136	205,136 $7.7 Million

258

49.2M

1.03M

139K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.14B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.